Sign in
NAVBQ Stock Price, Chart, Stats & News
Navidea Biopharmaceuticals, Inc.
Save
Navidea Biopharmaceuticals, Inc. (NAVBQ) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
NAVBQ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -259.40% |
Operating margin | -21402.08% |
Pretax margin | -23117.58% |
Net margin | -23117.58% |
Effective tax rate | – |
ROA | -347.18% |
ROE | 355.34% |
D/E | -0.29x |
Interest coverage ratio | -12.79x |
NAVBQ valuation
P/E | – |
P/S | 0.00x |
P/B | -0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | 0.03x |
About
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical firm dedicated to advancing and commercializing specialized agents for immunodiagnosis and innovative immunotherapeutics. The company operates across two distinct segments: Diagnostic Substances and Therapeutic Development Programs. Its core technology, the Manocept platform, is designed to target the CD206 mannose receptor, which is prominently found on activated macrophages.
Similar securities
Based on sector and market capitalization
Report issue